اخبار بازار

آخرین اخبار مالی و اقتصادی، تحولات بازار، گزارش‌ها و تحلیل‌های بازارهای مالی را در PipVero دنبال کنید.

منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know

Ulta Beauty (ULTA) Increases Yet Falls Behind Market: What Investors Need to Know

In the closing of the recent trading day, Ulta Beauty (ULTA) stood at $543.86, denoting a +1.77% move from the preceding trading day.

نمادهای مرتبط 1
ULTA ULTA
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Toll Brothers (TOL) Exceeds Market Returns: Some Facts to Consider

Toll Brothers (TOL) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Toll Brothers (TOL) settling at $153.24, representing a +1.85% change from its previous close.

نمادهای مرتبط 1
TOL TOL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know

Oracle (ORCL) Outpaces Stock Market Gains: What You Should Know

In the closing of the recent trading day, Oracle (ORCL) stood at $145.74, denoting a +2.74% move from the preceding trading day.

نمادهای مرتبط 1
ORCL ORCL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Why Gold.com (GOLD) Outpaced the Stock Market Today

Why Gold.com (GOLD) Outpaced the Stock Market Today

The latest trading day saw Gold.com (GOLD) settling at $42.9, representing a +1.83% change from its previous close.

نمادهای مرتبط 1
GOLD GOLD
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Intuit (INTU) Advances But Underperforms Market: Key Facts

Intuit (INTU) Advances But Underperforms Market: Key Facts

In the closing of the recent trading day, Intuit (INTU) stood at $323.6, denoting a +1.64% move from the preceding trading day.

نمادهای مرتبط 1
INTU INTU
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing

Home Depot (HD) Surpasses Market Returns: Some Facts Worth Knowing

Home Depot (HD) concluded the recent trading session at $348.24, signifying a +2.42% move from its prior day's close.

نمادهای مرتبط 1
HD HD
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Seeking Alpha خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
SpaceX Q2: A Monster Beat, A Broken Valuation (Strong Sell)

SpaceX Q2: A Monster Beat, A Broken Valuation (Strong Sell)

Space Exploration Technologies Corp. aka SpaceX delivered a spectacular Q2, with $7.81B in revenue and $3.54B in adjusted EBITDA, beating expectations across nearly every major business line. Yet SPCX stock fell about 8% after earnings. Investors were not questioning the growth; they were questioning how much capital SpaceX must spend to produce it. Starlink remains the economic engine of the group, generating $4.29B in revenue and $1.66B in operating profit while AI and Space posted combined operating losses of roughly $1.80B.

نمادهای مرتبط 1
SPCX SPCX
منبع: Seeking Alpha
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

Syndax Pharmaceuticals (SNDX) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to a loss of $0.83 per share a year ago.

نمادهای مرتبط 1
SNDX SNDX
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel Pharmaceuticals (RIGL) Q2 Earnings Miss Estimates

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.88 per share, missing the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $3.28 per share a year ago.

نمادهای مرتبط 1
RIGL RIGL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) Reports Q2 Loss, Tops Revenue Estimates

Personalis (PSNL) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.23 per share a year ago.

نمادهای مرتبط 1
PSNL PSNL
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Lumen (LUMN) Reports Q2 Loss, Tops Revenue Estimates

Lumen (LUMN) Reports Q2 Loss, Tops Revenue Estimates

Lumen (LUMN) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.03 per share a year ago.

نمادهای مرتبط 1
LUMN LUMN
منبع: Zacks Investment Research
مشاهده منبع
Official Partner ITBFX Start Trading
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Allegiant Travel (ALGT) Q2 Earnings Beat Estimates

Allegiant Travel (ALGT) Q2 Earnings Beat Estimates

Allegiant Travel (ALGT) came out with quarterly earnings of $2.19 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.23 per share a year ago.

نمادهای مرتبط 1
ALGT ALGT
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر
منبع: Zacks Investment Research خبرگزاری
یک ماه پیش
سهام اهمیت متوسط
Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates

Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates

Gilead Sciences (GILD) came out with a quarterly loss of $6.75 per share versus the Zacks Consensus Estimate of a loss of $7.07. This compares to earnings of $2.01 per share a year ago.

نمادهای مرتبط 1
GILD GILD
منبع: Zacks Investment Research
مشاهده منبع
0 0 0
ادامه مطلب
نظر